Kavar Capital Partners Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $219K | Buy |
|
|||||
|
2025
Q2 | $220K | Hold |
|
|||||
|
2025
Q1 | $290K | Hold |
|
|||||
|
2024
Q4 | $269K | Hold |
|
|||||
|
2024
Q3 | $246K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $285K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $211K | Hold |
|
|||||
|
2022
Q1 | $201K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $274K | Hold |
|
|||||
|
2019
Q3 | $217K | Hold |
|
|||||
|
2019
Q2 | $194K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $250K | Hold |
|
|||||
|
2018
Q2 | $223K | Sell |
|
|||||
|
2018
Q1 | $293K | Sell |
|
|||||
|
2017
Q4 | $308K | Hold |
|
|||||
|
2017
Q3 | $320K | Buy |
|
|||||
|
2017
Q2 | $269K | Hold |
|
|||||
|
2017
Q1 | $262K | Hold |
|
|||||
|
2016
Q4 | $282K | Hold |
|
|||||
|
2016
Q3 | $260K | Hold |
|
|||||
|
2016
Q2 | $355K | Hold |
|
|||||
|
2016
Q1 | $308K | Hold |
|
|||||
|
2015
Q4 | $331K | Hold |
|
|||||
|
2015
Q3 | $285K | Hold |
|
|||||
|
2015
Q2 | $321K | Hold |
|
|||||
|
2015
Q1 | $311K | Sell |
|
|||||
|
2014
Q4 | $288K | Sell |
|
|||||
|
2014
Q3 | $251K | Sell |
|
|||||
|
2014
Q2 | $238K | Sell |
|
|||||
|
2014
Q1 | $257K | Buy |
|
|||||
|
2013
Q4 | $261K | Buy |
|